serine/threonine Kinase 17a (STK17A) (N-Term) Peptide
STK17A
Reactivité: Humain
BP
Sodium azide
N° du produit ABIN1382030
Aperçu rapide pour serine/threonine Kinase 17a (STK17A) (N-Term) Peptide (ABIN1382030)
Antigène
STK17A
(serine/threonine Kinase 17a (STK17A))
Origine
Humain
Application
Blocking Peptide (BP)
-
-
Protein Region
- N-Term
-
Attributs du produit
-
15 amino amino terminus of human DRAK1.
Human
-
-
-
-
Indications d'application
- DRAK1 peptide is used for blocking the activity of DRAK1.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 200 μg/mL
-
Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Date de péremption
- 12 months
-
-
- STK17A (serine/threonine Kinase 17a (STK17A))
Antigène
-
Vous êtes ici:
